Zylox-Tonbridge Medical Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:818 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
09 Dec 24	Sell€128,762	Schroder Investment Management (Hong Kong) Ltd.	Company	96,000	€1.34
03 Jul 24	Sell€3,568,024	Zhuhai Guichuang Equity Investment Center (Limited Partnership)	Company	2,509,105	€1.42
03 Jul 24	Sell€1,415,714	Zhuhai Tongqiao Investment Center (Limited Partnership)	Company	995,558	€1.42
03 Jul 24	Sell€1,608,158	Huzhou Guiqiao Enterprise Management Partnership (Limited Partnership)	Company	1,130,888	€1.42
03 Jul 24	Sell€1,940,288	Hangzhou Fujiang Investment Partnership (Limited Partnership)	Company	1,364,449	€1.42
02 Jul 24	Sell€5,591,084	AIHC Capital Management Limited	Company	3,919,000	€1.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 818?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	4,983,293	1.5%
Hedge Funds	18,052,991	5.43%
Employee Share Scheme	36,370,587	10.9%
General Public	56,687,607	17.1%
VC/PE Firms	68,805,240	20.7%
Individual Insiders	71,170,033	21.4%
Institutions	76,331,250	23%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.62% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.5%	Zhong Zhao	41,441,991	€56.0m	0%	no data
7.62%	OrbiMed Advisors LLC	25,335,535	€34.3m	0%	0.57%
6.92%	HighLight Capital	22,999,506	€31.1m	0%	33.32%
6.16%	SDIC Innovation Investment Management Co., Ltd.	20,470,199	€27.7m	0%	1.59%
5.5%	AIHC Capital Management Limited	18,270,742	€24.7m	0%	no data
5.43%	Lake Bleu Capital (Hong Kong) Limited	18,052,991	€24.4m	0%	28.56%
4.87%	Snow Lake Capital (HK) Ltd	16,200,000	€21.9m	-2.41%	8.47%
4.82%	Schroder Investment Management (Hong Kong) Limited	16,007,500	€21.6m	0%	0.11%
4.29%	Yang Xie	14,251,425	€19.3m	0%	no data
4.05%	Shengping Zhong	13,476,617	€18.2m	0%	no data
3.3%	Zhuhai Guichuang Equity Investment Center (Limited Partnership)	10,958,575	€14.8m	0%	no data
3.05%	Zhuhai Tongqiao Investment Center (Limited Partnership)	10,151,978	€13.7m	0%	no data
2.88%	Huzhou Guiqiao Enterprise Management Partnership (Limited Partnership)	9,577,095	€13.0m	0%	no data
1.88%	Highlight Medical Limited	6,263,113	€8.5m	0%	100.0%
1.71%	Hangzhou Fujiang Investment Partnership (Limited Partnership)	5,682,939	€7.7m	0%	no data
1.69%	Morgan Stanley, Investment Banking and Brokerage Investments	5,622,400	€7.6m	0%	no data
1.5%	Nanjing Yuyihui Business Management Partnership Enterprise (Limited Partnership)	4,983,293	€6.7m	0%	no data
0.91%	Cormorant Asset Management, LP	3,027,598	€4.1m	0%	0.26%
0.8%	Hudson Bay Capital Management LP	2,649,148	€3.6m	0%	0.05%
0.6%	Myron Scholes	2,000,000	€2.7m	0%	no data
0.57%	Octagon Capital Advisors LP	1,892,249	€2.6m	0%	0.43%
0.55%	Mediolanum Asset Management Limited	1,834,500	€2.5m	0%	0.02%
0.52%	Schroder Investment Management (Singapore) Ltd	1,743,500	€2.4m	0%	0.02%
0.35%	Schroder Investment Management Limited	1,172,500	€1.6m	0%	no data
0.17%	Schroder Investment Management North America Inc.	552,500	€747.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/03/20 03:07
End of Day Share Price	2022/12/22 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zylox-Tonbridge Medical Technology Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shuo Song	Citic Securities Co., Ltd.
null null	Guoyuan Securities (HK) Ltd
Youjue Hu	Morgan Stanley